Connect with us

Hi, what are you looking for?

Jewish Business News

Syndicated

7th Pharmacovigilance 2014

7th Pharmacovigilance 2014

Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

7th Pharmacovigilance 2014

Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

Online PR News – 19-September-2014 – 7th Pharmacovigilance 2014

Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

21st November 2014, Kohinoor Continental Hotel, Mumbai, India

Key Themes Discussed at this Summit:

Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
Identifying the latest regulatory framework for pharmacovigilance
Crisis management within drug safety
Impact of technology learn and explore
Explaining how to use the data sources and observational research for effective safety analysis
Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
Stay ahead of computing and electronic communications in pharmacovigilance
Risk management plans
Risk/benefit determinations
Implications for safety reporting in global clinical trials
Compliance and drug safety
Training for drug safety – reporting duties, audits and expectations risk based inspections
Safety reporting in licensing agreement
Good supply chain management practices for medicine distribution
Accelerating new medicine introduction in developing world & overcoming challenges
Analyzing the information on current industry projects and trends
How will PV activities change with clinical trial transformation initiative?
Recent successful strategies and business models to bring out new medicines
Exploiting the pharmacy automations and technologies for enhancement of medication safety
Determining the steps and strategies for enhancing quality in healthcare
Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions

Key Speakers:

Mazhar Maruf, Head of Pharmacovigilance, Glenmar
Karthik Babu, Affiliate Pharmacovigilance Head, Sanofi
Abhay Chimankar, Head – Global Drug Safety, Cipla
Rahul Chauhan, Associate Director Regulatory Affairs & Pharmacovigilance, Eli Lilly
Abhay Phansalkar, Head – Medical Affairs, Wockhardt
Bhaswat Chakraborty, Senior Vice President, Cadila
Babita Kirodian, Head of Country Pharmacovigilance, Bristol Myers Squibb
Manish Verma, Director Medical Affairs, Sanofi
Indu Nambiar, Clinical Safety Officer, Boehringer Ingelheim
Amit Arora, Head Medical Affairs, Merck Serono
Manish Shah, General Manager, Global Clinical Operations, Wockhardt
V K Sharma, Associate Vice President, Unichem Laboratories
Girish Parhate, Senior Manager Regulatory Affairs, Bayer
Kamlesh Patel, GM, Medical Affairs & Pharmacovigilance, Abbott
Milind Antani, Head – Pharma LifeSciences, Nishith Desai Associates
Vandana Jolad Shivangi, Director, VIaTAL Pharma Consulting
Plus Many More…

Target Audiance-Industry:-

Pharmaceutical organisations
Generic pharmaceutical companies
Contract research organisations
Patient recruitment companies
Government- Department of health
Non-profit organisations/ Association
Consultans

Who Should Attend:-

Vice Presidents, Directors, CROs, Heads and Managers of:
Pharmacovigilance Strategy
Drug Safety/Risk Management
Information and Clinical Data Management
Clinical Research
Research & Development
Product Safety/Assurance Assessment
Patient Safety & Outcomes Research & Data Analysis
Epidemiology project management
Regulatory Affairs and Compliance
Sales & Marketing
Biotech manufacturers

Why Should You Attend:

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference

Conference Booking Details:

Early Bird Discounted Price – Conference Delegate Pass (INR 6, 000 + Tax (12.36%) per delegate) – Book and Pay before 07th October 2014 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 7401150416. Email nisha @ virtueinsight . co . in

Standard Price after early bird discounted time – 1 or 2 Delegates (INR 7, 000 + Tax (12.36%) per delegate) – You can simply email or call and book your conference delegate seats on TEL: + 91 7401150416. Email nisha @ virtueinsight . co . in

Group Discounts – 3 or 4 Delegates – (INR 6, 500 + Tax (12.36%) per delegate)

Group Discounts – 5 and above Delegates – (INR 5, 000 + Tax (12.36%) per delegate)

Spot Registration on the day of the conference – 1 Day Conference – (INR 8, 000 + Tax (12.36%) per delegate)

Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to TEL: + 91 7401150416. Email – nisha @ virtueinsight . co . in

Company Contact Information
Nisha
http://www.virtueinsight.com/pharma/7th-Pharmacovigilance-2014/
+917401150416
 
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement
cialis